发明名称 METHOD FOR CORRECTION OF BLOOD MICROVESICLE LEVEL IN ARTERIAL HYPERTENSION WITH IMPAIRED GLUCOSE TOLERANCE
摘要 FIELD: medicine. ^ SUBSTANCE: invention refers to medicine, namely to haematology, cardiology and endocrinology, and concerns correction of blood microvesicle level in arterial hypertension with impaired glucose tolerance. That is ensured by integrated treatment including graduated physical exercises, and introduction of Fosinopril in a dose 10 mg once in the morning and pioglitazone in a dose 30 mg once in the morning. Therapeutic course is at least 7 weeks. ^ EFFECT: complex of drug-free modalities and specific pharmacological preparations combined with empirically specified time of treatment provides maintained optimum microvesicle level that in turn allows considerably reducing risk of thrombotic complications in given group of patients. ^ 1 ex
申请公布号 RU2373931(C1) 申请公布日期 2009.11.27
申请号 RU20080120012 申请日期 2008.05.20
申请人 MEDVEDEV IL'JA NIKOLAEVICH 发明人 MEDVEDEV IL'JA NIKOLAEVICH
分类号 A61H1/00;A61K31/401;A61K31/426;A61P5/50;A61P9/12 主分类号 A61H1/00
代理机构 代理人
主权项
地址